Search - tctmd.com

Displaying 701 - 720 of 1378

Sort: Relevancy | Date

News Daily News

LEVANT 2: Un BRF Supera a la Angioplastia con Balón Estándar al cabo de 1 Año en el Manejo de la Enfermedad Femoropoplítea

Yael L. Maxwell

June 26, 2015

News Daily News

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

Yael L. Maxwell

June 26, 2015

News Industry News

U.S. to vie with India for top bioabsorbable stent market after FDA approval

June 25, 2015

Presentation CCVVC 2015

Endovascular Management of SFA Instent Restenosis: Role of Atherectomy Drug-Eluting Stents

Presenter: Craig M. Walker

June 18, 2015

Presentation CCVVC 2015

Drug Eluting Stents in the treatment of SFA disease: Data and Current Trends

Presenter: Suhail Dohad

June 18, 2015

News Daily News

Con los SLF de Nueva Generación, la Implantación de Stents Ultralargos se asoció a Episodios Adversos

Nicole Lou

June 16, 2015

News Daily News

Un Meta Análisis Confirma la Seguridad Tardía de los SLF de 2ª Generación

L.A. McKeown

June 10, 2015

News Daily News

Meta-analysis Confirms Late Safety of Second-Generation DES

L.A. McKeown

June 10, 2015

News Daily News

Meta 分析证实了第二代 DES 的晚期安全性

L.A. McKeown

June 10, 2015

News Daily News

ISAR-DESIRE 3: Un Balón Recubierto de Fármaco Confiere un Efecto Reestenótico Duradero en la Reestenosis del SLF

L.A. McKeown

June 03, 2015

News Daily News

ISAR-DESIRE 3: Drug-Coated Balloon Shows Durable Antirestenotic Effect in DES Restenosis

L.A. McKeown

June 03, 2015

News Industry News

Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies

May 28, 2015

News Industry News

China Interventional Cardiovascular Device Industry Report, 2014-2017

May 27, 2015

News Conference News EuroPCR 2015

Trials Explore the Potential of Biodegradable-Polymer Stents

Caitlin E. Cox

May 21, 2015

News Conference News EuroPCR 2015

MASTER: Biodegradable-Polymer DES Tested Against BMS in STEMI

Caitlin E. Cox

May 20, 2015

News Industry News

Early Healing Profile Established for BioFreedom

May 20, 2015

News Industry News

New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years

May 19, 2015

News Conference News EuroPCR 2015

Evolving DES Technology May Benefit Diabetic Patients

Caitlin E. Cox

May 19, 2015

News Industry News

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

May 19, 2015

News Industry News

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

May 19, 2015

Advertisement

LEVANT 2: Un BRF Supera a la Angioplastia con Balón Estándar al cabo de 1 Año en el Manejo de la Enfermedad Femoropoplítea

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

U.S. to vie with India for top bioabsorbable stent market after FDA approval

Endovascular Management of SFA Instent Restenosis: Role of Atherectomy Drug-Eluting Stents

Drug Eluting Stents in the treatment of SFA disease: Data and Current Trends

Con los SLF de Nueva Generación, la Implantación de Stents Ultralargos se asoció a Episodios Adversos

Un Meta Análisis Confirma la Seguridad Tardía de los SLF de 2ª Generación

Meta-analysis Confirms Late Safety of Second-Generation DES

Meta 分析证实了第二代 DES 的晚期安全性

ISAR-DESIRE 3: Un Balón Recubierto de Fármaco Confiere un Efecto Reestenótico Duradero en la Reestenosis del SLF

ISAR-DESIRE 3: Drug-Coated Balloon Shows Durable Antirestenotic Effect in DES Restenosis

Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies

China Interventional Cardiovascular Device Industry Report, 2014-2017

Trials Explore the Potential of Biodegradable-Polymer Stents

MASTER: Biodegradable-Polymer DES Tested Against BMS in STEMI

Early Healing Profile Established for BioFreedom

New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years

Evolving DES Technology May Benefit Diabetic Patients

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content